words lines 0 60 0 20 top 50% bottom top 1 0 0 .22 back 1 0 .001 1 .1 1.5 none top bottom center center true 1 none top top center top true 0 200 .001 none
top bottom top center true 1 none top bottom bottom bottom true 1 none

CEO Raman Singh speaks about his mission to bring accessibility to the core of pharmaceutical innovation while being committed to ESG.

Oct 12, 2022

Juniper Biologics

Author


Mind Your Business: Striking a balance between pharmaceutical innovation and accessibility to medication

The pharmaceutical industry has gone through heaps and bounds of multiple shake ups due to the Covid-19 pandemic. And as we move forward, it has become more important than ever to strike a balance between pharmaceutical innovation and accessibility to medication.

Raman Singh, Chief Executive Officer, Juniper Biologics shares with us on how his company are looking ways to support Singapore’s efforts to be the next frontier in pharmaceutical services. 

MoneyFM
CEO Raman Singh speaks about his mission to bring accessibility to the core of pharmaceutical innovation while being committed to ESG.
Juniper_Announcement_Changes
Juniper Biologics Establishes Global Headquarters in Singapore 
legada2
Helsinn Healthcare SA signs exclusive license agreement with Juniper Biologics Pte. Ltd. for LEDAGA® (chlormethine) in Australia, Asia and the Middle East*
Follow us on Facebook